Mehreen Datoo
@DrMSDatoo
Infectious Diseases/Microbiology Clinical Lecturer @UniofOxford @JennerInstitute. Views my own.
You might like
The phase II results of our malaria vaccine demonstrating 77% efficacy can now be found in the Lancet @HalTinto @ProfKatieEwer thelancet.com/journals/lance…
NEW: Oxford R21 malaria vaccine receives @WHO recommendation paving the way for global roll-out. The vaccine developed by Oxford & @SerumInstIndia demonstrates a high efficacy. The jab could reduce over half a million malaria-related deaths annually. #OxfordVaccine
Our malaria vaccine - co-developed with @SerumInstIndia - can be manufactured at mass scale and modest cost, enabling as many as 100s of millions of doses to be supplied to African countries which are suffering a significant malaria burden. #OxfordVaccine ox.ac.uk/news/2023-10-0…
'The goal is to completely eradicate malaria.' The researchers behind Oxford's malaria vaccine share why the jab could be a potential game-changer in Africa. #OxfordVaccine
Our promising phase III R21/MM malaria vaccine starts in Mali
ℹ️ | Malaria vaccine update First vaccinations have now begun in Mali in a phase III trial of a malaria vaccine developed at @UniofOxford. It is hoped that this phase III trial will help lead to licensure of the vaccine by 2023. More info ⬇️
NEW: Oxford researchers find malaria vaccine is highly effective: • Vaccine efficacy of 77% in African children • Vaccine, trialled in 450 children, shows favourable safety profile and was well-tolerated More info ⬇️ bit.ly/3dP47fH
Today is #WorldMalariaDay. We are excited to be starting large-scale safety and efficacy trials across four African countries, in 4,800 children aged 5-36 months.
NEW: Oxford researchers find malaria vaccine is highly effective: • Vaccine efficacy of 77% in African children • Vaccine, trialled in 450 children, shows favourable safety profile and was well-tolerated More info ⬇️ bit.ly/3dP47fH
In 2017 @WHO launched the E-2020 initiative to support 21 countries in their efforts to get to zero #malaria cases by 2020. Today we report on the progress and the exciting addition of a new group of 25 countries w/the potential to #EndMalaria by 2025. 📢bit.ly/3emDcGS
Amazing results from a Phase 2 study of #R21 the #malaria #vaccine I made in the lab 8 years ago! 77% efficacy! So proud to have played a part. Huge congratulations to the whole team who made this happen @JennerInstitute @HalTinto @DrMSDatoo @SerumInstIndia @ProfKatieEwer
Our exciting malaria vaccine results from Burkina Faso @HalTinto @ProfKatieEwer @Kat_a_Collins @JennerInstitute @SerumInstIndia @Novavax papers.ssrn.com/sol3/papers.cf…
United States Trends
- 1. Jack Smith N/A
- 2. Fanone N/A
- 3. Arlington N/A
- 4. Fable N/A
- 5. He-Man N/A
- 6. Stanford N/A
- 7. Titanic N/A
- 8. Sinners N/A
- 9. Gore N/A
- 10. Don Lemon N/A
- 11. Ivan N/A
- 12. Oscar N/A
- 13. Nehls N/A
- 14. Maki N/A
- 15. Rich Paul N/A
- 16. Hanoi Jane N/A
- 17. MetLife N/A
- 18. Nats N/A
- 19. harry styles N/A
- 20. Brex N/A
Something went wrong.
Something went wrong.